Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 24;17(3):214-219.
doi: 10.4274/ejbh.galenos.2021.2021-3-4. eCollection 2021 Jul.

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options

Burcu Altıparmak Güleç  1 , Fatma Yurt  2
Affiliations
Review

Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options

Burcu Altıparmak Güleç et al. Eur J Breast Health. .

Abstract

Radiopharmaceutical therapy (RPT) is an effective and safe treatment for many types of cancer. RPT acts by binding radioactive atoms to tumor-associated antigens, monoclonal antibodies, nanoparticles, peptides, and small molecules. These treatments ensure that a concentrated dose is delivered to the targeted tumor tissue while preserving the normal tissues surrounding the tumor. Given these features, RPT is superior to traditional methods. This review article aimed to performa comprehensive review and evaluation of the potential of radionuclides and radiopharmaceuticals used in breast cancer treatment in preclinical studies conducted in the last five years.

Keywords: Breast cancer; radioisotopes; radionuclide therapy; radiopharmaceuticals.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization. Cancer Report, September 2018. Available from: [Internet] https://www.who.int/health-topics/cancer#tab=tab_1 .
    1. Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9:217–222. - PMC - PubMed
    1. Kayano D, Kinuya S. Current consensus on 131I-MIBG therapy. Nucl Med Mol Imaging. 2018;52:254–265. - PMC - PubMed
    1. Das S, Al-Toubah T, El-Haddad G, Strosberg J. 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2019;13:1023–1031. - PMC - PubMed
    1. Fendler WP, Rahbar K, Herrmann K, Kratochwil C, Eiber M. 177Lu-PSMA radioligand therapy for prostate cancer. J Nucl Med. 2017;58:1196–1200. - PubMed

LinkOut - more resources